Aducanumab: A Deep Dive into BIIB037 and its Impact This medication, originally known as BIIB037, represents a significant attempt to combat emerging Alzheimer's condition. Developed by Biogen, aducanumab acts by https://www.targetmol.com/compound/aducanumab